CNE Index: Webcasts

31st Annual ONS Congress (2006) Webcasts
Contact Hours Vary
Expires: 6/1/08

We invite you to take advantage of the opportunity to LISTEN to the lectures and VIEW the slides from select sessions from this dynamic conference. Check out these webcasts today!

32nd Annual ONS Congress (2007) Webcasts
Contact Hours Vary
Expires: 9/18/09

You're invited to LISTEN and VIEW the material presented during several sessions of the 32nd Annual Congress in Las Vegas April 24-27. Earn valuable contact hours viewing sessions with topics such as Advances in the Prevention of Cervical Cancer, Current Trends in Neutropenic Fevers and Sepsis, and Managing Pain in Cognitively Impaired Patients. Learn more today!

Adherence Issues in the Aging Client
1.6 Contact Hours
Expires: 9/18/09
This webcast is supported by an unrestricted educational grant from AstraZeneca LP and Abraxis Bioscience, Inc.

A person’s adherence to their plan of care is potentially compromised by many factors, including neurosensory and psychosocial issues. Non-adherence can lead to altered doses, altered schedules, altered pharmacokinetics, and other potentially harmful patient outcomes. Learn more.

Advanced Renal Cell Carcinoma Webcast
1.8 Contact Hours
Expires: 6/30/09
Supported by an educational grant from Wyeth Pharmaceuticals to the Oncology Nursing Society.

Don't miss this webcast recorded from a satellite symposium presented at the 2007 ONS 32nd Annual Congress, in Las Vegas. Highlights include an evidence-based discussion of advanced renal cell carcinoma (RCC), including treatment and symptom management strategies. Learn more about this superb webcast.

Advances in the Prevention of Cervical Cancer
1.4 Contact Hours
Expires: 9/18/09
This webcast is supported by an unrestricted educational grant from Merck & Co., Inc.

Cervical cancer is the 2nd most common cancer in women and a leading cause of morbidity and mortality worldwide. Participants will learn about current strategies in managing pre-invasive and invasive cervical cancer, screening and early detection strategies, and new prevention strategies including HPV vaccines. Learn more.

Applying New Data to Manage CINV: Achieving optimal outcomes through a comprehensive care model
2.5 Contact Hours
Expires: 10/01/08
This webcast is supported by an unrestricted educational grant from Merck & Co., Inc.

Clinical experts will review the newest data and evidence-based guidelines for managing CINV through interactive case studies that focus on a team-care approach.
This webcast will provide an interactive case study discussion where clinical experts will review the newest data and evidence-based guidelines for managing CINV. The panel will focus on a team-care approach, providing perspectives of the nurse, physician, and pharmacist. The faculty will discuss ways to optimize patient outcomes in both the inpatient and outpatient settings.
Take CNE Test

Breast Health: It's Everybody's Business – Part I
2.2 Contact Hours
Expires: 4/9/09

Part one of this institute focuses on the breast care continuum from normal breast health, screening and high risk guidelines, with an introduction to breast cancer treatment. The presenters use a case study approach and employ audience response technology to provide an interactive experience.
View Webcast | Take CNE Test

Breast Health: It's Everybody's Business – Part II
2.5 Contact Hours
Expires: 4/9/09

Part two of this institute discusses treatment options in greater detail and reviews the implications of high-risk management for various pathological diagnoses, potential treatment pathways, and emerging therapies related to the care of persons with breast cancer. Psychosocial issues including body image concerns and survivorship issues will also be highlighted. This session concludes with a panel discussion of various nurse navigators’ roles, along with useful information in planning and implementing a successful breast health program in your community.
View Webcast | Take CNE Test

Cervical Cancer
2.2 Contact Hours
Expires: 4/2/09

Cervical cancer is one of the leading causes of morbidity and mortality in women worldwide. Persistent infection with oncogenic forms of Human Papilloma Virus (HPV), most frequently contracted through vaginal intercourse, is necessary for the development of cervical cancer and high-grade precursor lesions. HPV is the most prevalent sexually transmitted disease. This session focuses on the epidemiology, etiology, prevention and early detection, diagnosis, staging, and management of both pre-invasive and invasive cervical cancer. Recent advances in surgery, radiation, and chemotherapy are reviewed and nursing management of these patients are highlighted. A cervical cancer survivor presents her story and what it means to live with cervical cancer.
View Webcast | Take CNE Test

Clinical Breakthroughs in EGFR Inhibition: Applying the Science to Your Clinical Practice
2.1 Contact hours
Expires: 10/01/08
This webcast is supported by an educational grant from Amgen, Inc.

What are the hottest new clinical developments in targeted therapies?
This webcast takes a fascinating look at EGFR inhibition, including an illustrated explanation of cellular changes, a clinical review of promising new treatments, and a comprehensive discussion of side effects and their management. Participants will gain a clear understanding of how side effects correlate with treatment progression and with proven strategies to successfully manage the side effects of EGFR inhibitors.
Take CNE Test

Clinical Trials: Opening the Door for the Underserved
1.0 Contact Hour
Expires: 6/22/09
This program is supported by an educational grant from the Lance Armstrong Foundation.

Whether you currently work with patients on clinical trials in your practice or not, this webcast will provide you with the resources and information you need to increase your patients' knowledge about and opportunities for participation in clinical trials. With a focus on those patient groups who are least represented in clinical trials, this program will provide you with strategies to address the barriers that prevent many from receiving the benefits of clinical trials.

Current Trends in Neutropenic Fevers and Sepsis
1.5 Contact Hours
Expires: 9/18/09

Neutropenic patients are susceptible to a wide range of complications and rare infections that can lead to sepsis. During this presentation faculty discuss the pathogenesis, predisposing factors, and evaluation and management of neutropenic fevers. Learn more.

The Cytokines and the B-Cell Malignancies: A New Spin on Maximizing Therapeutic Outcomes
1.4 Contact Hours
Expiration: 10/01/2008
This webcast is supported by an educational grant from Berlex Oncology, Inc.

Treatments for B-cell malignancies have shown great promise in overall survival and in improving quality of life. This case study-based webcast will examine the latest data in treating follicular lymphoma, large B-cell lymphoma, and chronic lymphocytic leukemia, including chemotherapy and targeted agents. Gain insight into the critical role that antibody-dependent cellular cytotoxicity plays in targeting malignant B-cells and what this means for your practice and your patients.
Take CNE Test

Developing a Clinical Program for Survivorship
1.6 Contact Hours
Expires: 9/18/09
This webcast is supported by an unrestricted educational grant from the Lance Armstrong Foundation.

This session provides an overview of survivorship care models in both the adult and pediatric settings and describe the essential elements of survivorship care. Speakers discuss examples from their clinical experience to describe the implementation of a comprehensive survivorship program and the provision of care for cancer survivors. Learn more.

Developing and Implementing a Successful Nurse Navigator Program in Your Community
1.9 Contact Hours
Expires: 9/18/09
This webcast is sponsored by the Breast Care Special Interest Group.

Navigating the complex maze of cancer care is a challenge for patients and their caregivers. A relatively new role for oncology nurses is that of “nurse navigator.” Nurse navigators, known as case managers or care coordinators, are experienced oncology nurses who provide guidance to patients to help them understand their diagnosis, treatment options, and to guide them through the various community and supportive resources available to them. Learn more.

DIC: A Case Study in APL
1.1 Contact Hours
Expires: 9/18/09
Supported by an educational grant from Cephalon, Inc.

DIC is often a forgotten emergency in the oncology patient. This session is a comprehensive review of the coagulation cascade, physiology of DIC and Acute Leukemia. It evaluates the subset of patients at highest risk for DIC and provide illustrations of the clinical presentation of Acute Leukemia including pathophysiology, current treatment modalities and nursing strategies for management. Learn more.

Improving Patient Outcomes: Managing Anemia, Maintaining Treatment Goals, Maximizing Quality of Life
1.6 Contact Hours
Expires: 10/01/08
Supported by an educational grant from Amgen, Inc.

This webcast will provide an in-depth discussion of clinical evaluation, current evidence, practice guidelines, and best practices to manage anemia. The faculty will review several case studies comparing treatment approaches and their effect on patient outcomes.
Take CNE Test

The Individual and The Evidence: Treating Advanced Non-Small Cell Lung Cancer
Expiration: 7/9/2009
1.2 Contact Hours
Supported by sanofi-aventis, u.s.inc.

Why Participate in this Awesome New Webcast? The Individual and The Evidence: Treating Advanced Non-Small Cell Lung Cancer' webcast will provide you with the means to challenge current thinking about individualized treatment of patients with non-small cell lung cancer, including dose-intense therapy and improved patient outcomes. Learn more about this session which also provides approximately 20 minutes of pharmacology content.

Individualizing Therapeutic Decision-Making in Early Stage Breast Cancer
Contact Hours: 2.0 with approximately 30 minutes of pharmacology content
Expires: 10/9/09
Supported by an educational grant from Genomic Health, Inc.

This program explores individualizing decision-making about early-stage breast cancer adjuvant therapy, comparing choices made using traditional treatment guidelines, Adjuvant!Online, MammaPrint, and Oncotype DX™. The methods are summarized and compared in their clinical utility at providing individually tailored therapeutic decisions based on relevant patient characteristics. Learn more.

Late effects of Cancer Survivorship
2.0 Contact Hours
Expires 2/19/10
This webcast is supported by the Lance Armstrong Foundation.

This timely webcast focuses upon the myriad of issues that have been identified by patients  following treatment for cancer.  Topics such as sexuality, fatigue, anxiety and many others are presented by a diverse faculty. 

Managing Pain in Cognitively Impaired Patients
1.6 Contact Hours
Expires: 9/18/09
Supported by an educational grant from Kyphon Inc.

Speakers engaged participants in discussions about the under-treatment of pain, assessment techniques for cognitively impaired patients, and tools to evaluate cognitive impairment. Case studies and interactive discussion enhances your confidence to apply this information to your practice. Learn more.

New Management Strategies for CINV
Coming Soon!
Supported by an unrestricted educational grant from Merck, Inc.

Clinical experts will discuss new strategies for managing CINV, including recent data and evidence-based guidelines. Interactive vignettes and case studies will set the stage for a faculty led discussion of important issues such as quality of life, evaluating risk, uncontrolled CINV, and access to care.

Non-Pharmacologic Approaches to the Management of Vertebral Compression Fractures
1.1 Contact Hours
Expires 10/1/08
Supported by an educational grant from Kyphon, Inc.

Check out the FREE continuing nursing education (CNE) webcast, Non-Pharmacologic Approaches to the Management of Vertebral Compression Fractures from ONS! This webcast discusses the role of oncology nurses in caring for patients with cancer who have experienced vertebral compression fractures and in their treatment, including vertebroplasty and balloon kyphoplasty.

Nutritional Challenges in Oncology: Keys to Optimizing Patient Outcomes
1 Contact Hour
Expires: 5/17/10
This webcast is supported by an educational grant from Nestlé HealthCare Nutrition, Inc.

Find out the latest information and review the principles of nutrition for patients with cancer by visiting this webcast. Essential nutritional definitions will be among its topics, and you will have the opportunity to review methods of risk assessment and apply them in case studies. You will also explore various interventions for patients experiencing nutritional challenges and learn to recognize when nutrition is no longer of paramount concern at the end of life. View this webcast.

ONS Foundation Interdisciplinary Multi-Site Research Training Webcast
Join us for this in-depth webcast, based on live presentations from the 2006 ONS Foundation Interdisciplinary Multi-Site Research Training Program! You will learn about the National Cancer Institute (NCI) cooperative group structure and the research that these groups conduct. Learn More about this exciting new webcast!

Signal Transduction Pathways: Signposts to Improved Therapy for Advanced Renal Cell Carcinoma
1.8 Contact Hours
Expires: 9/18/09
Supported by an educational grant from Wyeth Pharmaceuticals.

This session provides an evidence-based discussion of advanced renal cell carcinoma (RCC), including treatment and symptom management strategies. Case discussion will give participants an opportunity to provide suggestions for assessment and interventions and to demonstrate their understanding of the implications. Learn more.

Unraveling the Mysteries of MDS—Linking Science to Practice through Case Studies
1.5 Contact Hours
Expires: 9/18/09
Supported by an educational grant from Pharmion, Inc.

Myelodysplastic syndrome (MDS) is a common bone marrow disorder. This lecture will focus on the clinical and laboratory features of MDS as well as the classification, risk stratification, and prognosis of MDS. The current FDA-approved treatments will be discussed. Case studies will be utilized to help participants determine appropriate treatment for selected patients. Learn more.

What’s Blasting Off in CML?
1.6 Contact Hours
Expires: 9/18/09
Supported by an educational grant from Novartis Oncology.

Chronic myelogenous leukemia (CML) is a complex disease that occurs in about 1 in 100,000 people. This webcast will include an overview of the genetic disease development and its phases. Through the presentation of case studies, the participant will gain an improved comprehension of the progression of the disease, current and possible future treatments, and how to identify patients at increased risk for relapse. Learn more.